Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
Brian G Feagan, Stefan Schreiber, Douglas C Wolf, Jeffrey L Axler, Arpeat Kaviya, Alexandra James, Rebecca I Curtis, Parnia Geransar, Andreas Stallmach, Robert Ehehalt, Bernd Bokemeyer, Javaria Mona Khalid, Sharon O’Byrne;Brian G Feagan;Stefan Schreiber;Douglas C Wolf;Jeffrey L Axler;Arpeat Kaviya;Alexandra James;Rebecca I Curtis;Parnia Geransar;Andreas Stallmach;Robert Ehehalt;Bernd Bokemeyer;Javaria Mona Khalid;Sharon O’Byrne;
inflammatory bowel diseases2019Vol. 25pp. 1028-
353
o’byrne2019inflammatorysustained
Abstract
Sustaining clinical remission is an important treatment goal in moderate-to-severe UC. This post hoc exploratory analysis assessed the long-term efficacy of vedolizumab in the subset of patients with UC in the GEMINI 1 study who were in clinical remission ...